Unique invariant CD8(+) T cell population persists in MS

por Sabatino, Joseph J., Zamvil, Scott S.
Publicado 2015

Aryl hydrocarbon receptor activity may serve as a surrogate marker for MS disease activity

por Sabatino, Joseph J., Zamvil, Scott S.
Publicado 2017

High prevalence of low affinity peptide–MHC II tetramer–negative effectors during polyclonal CD4(+) T cell responses

por Sabatino, Joseph J., Huang, Jun, Zhu, Cheng, Evavold, Brian D.
Publicado 2011

Acute liver injury in a Glatopa-treated patient with MS

por Sabatino, Joseph J., Mehta, Neil J., Kakar, Sanjay, Zamvil, Scott S., Cree, Bruce A.C.
Publicado 2017

Anti-CD20 therapy depletes activated myelin-specific CD8(+) T cells in multiple sclerosis

por Sabatino, Joseph J., Wilson, Michael R., Calabresi, Peter A., Hauser, Stephen L., Schneck, Jonathan P., Zamvil, Scott S.
Publicado 2019

Low 2-Dimensional CD4 T Cell Receptor Affinity for Myelin Sets in Motion Delayed Response Kinetics

por Rosenthal, Kristen M., Edwards, Lindsay J., Sabatino, Joseph J., Hood, Jennifer D., Wasserman, Heather A., Zhu, Cheng, Evavold, Brian D.
Publicado 2012

Self-reactive human CD4 T cell clones form unusual immunological synapses

por Schubert, David A., Gordo, Susana, Sabatino, Joseph J., Vardhana, Santosh, Gagnon, Etienne, Sethi, Dhruv K., Seth, Nilufer P., Choudhuri, Kaushik, Reijonen, Helena, Nepom, Gerald T., Evavold, Brian D., Dustin, Michael L., Wucherpfennig, Kai W.
Publicado 2012

Persistently reduced humoral and sustained cellular immune response from first to third SARS-CoV-2 mRNA vaccination in anti-CD20-treated multiple sclerosis patients

por Bajwa, Hamza Mahmood, Novak, Frederik, Nilsson, Anna Christine, Nielsen, Christian, Holm, Dorte K., Østergaard, Kamilla, Witt, Agnes Hauschultz, Byg, Keld-Erik, Johansen, Isik S., Mittl, Kristen, Rowles, William, Zamvil, Scott S., Bove, Riley, Sabatino, Joseph J., Sejbaek, Tobias
Publicado 2022

T cell deletional tolerance restricts AQP4 but not MOG CNS autoimmunity

por Sagan, Sharon A., Moinfar, Zahra, Moseley, Carson E., Dandekar, Ravi, Spencer, Collin M., Verkman, Alan S., Ottersen, Ole Petter, Sobel, Raymond A., Sidney, John, Sette, Alessandro, Anderson, Mark S., Steinman, Lawrence, Wilson, Michael R., Sabatino, Joseph J., Zamvil, Scott S.
Publicado 2023

SARS-CoV-2 variant exposures elicit antibody responses with differential cross-neutralization of established and emerging strains including Delta and Omicron

por Laurie, Matthew T, Liu, Jamin, Sunshine, Sara, Peng, James, Black, Douglas, Mitchell, Anthea M, Mann, Sabrina A, Pilarowski, Genay, Zorn, Kelsey C, Rubio, Luis, Bravo, Sara, Marquez, Carina, Sabatino, Joseph J, Mittl, Kristen, Petersen, Maya, Havlir, Diane, DeRisi, Joseph
Publicado 2021

SARS-CoV-2 Variant Exposures Elicit Antibody Responses With Differential Cross-Neutralization of Established and Emerging Strains Including Delta and Omicron

por Laurie, Matthew T, Liu, Jamin, Sunshine, Sara, Peng, James, Black, Douglas, Mitchell, Anthea M, Mann, Sabrina A, Pilarowski, Genay, Zorn, Kelsey C, Rubio, Luis, Bravo, Sara, Marquez, Carina, Sabatino, Joseph J, Mittl, Kristen, Petersen, Maya, Havlir, Diane, DeRisi, Joseph
Publicado 2022

Low protection from breakthrough SARS-CoV-2 infection and mild disease course in ocrelizumab-treated patients with multiple sclerosis after three mRNA vaccine doses

por Novak, Frederik, Bajwa, Hamza Mahmood, Coia, John Eugenio, Nilsson, Anna Christine, Nielsen, Christian, Holm, Dorte K, Østergaard, Kamilla, Hvidt, Mathilde Vilhelmine Miller, Byg, Keld-Erik, Johansen, Isik S, Mittl, Kristen, Rowles, William, Zamvil, Scott S, Bove, Riley, Sabatino, Joseph J, Sejbaek, Tobias
Publicado 2023

Humoral immune response following SARS-CoV-2 mRNA vaccination concomitant to anti-CD20 therapy in multiple sclerosis()

por Novak, Frederik, Nilsson, Anna Christine, Nielsen, Christian, Holm, Dorte K., Østergaard, Kamilla, Bystrup, Anna, Byg, Keld-Erik, Johansen, Isik S., Mittl, Kristen, Rowles, William, Mcpolin, Kira, Spencer, Collin, Sagan, Sharon, Gerungan, Chloe, Wilson, Michael R., Zamvil, Scott S., Bove, Riley, Sabatino, Joseph J., Sejbaek, Tobias
Publicado 2021

Longitudinal adaptive immune responses following sequential SARS-CoV-2 vaccinations in MS patients on anti-CD20 therapies and sphingosine-1-phosphate receptor modulators

por Sabatino, Joseph J., Mittl, Kristen, Rowles, William, Zamecnik, Colin R., Loudermilk, Rita P., Gerungan, Chloe, Spencer, Collin M., Sagan, Sharon A., Alexander, Jessa, Mcpolin, Kira, Chen, PeiXi, Deshpande, Chinmay, Wyse, Kerri, Maiese, Eric M., Wilson, Michael R., Zamvil, Scott S., Bove, Riley
Publicado 2023

Impact of multiple sclerosis disease-modifying therapies on SARS-CoV-2 vaccine-induced antibody and T cell immunity

por Sabatino, Joseph J., Mittl, Kristen, Rowles, William, Mcpolin, Kira, Rajan, Jayant V., Zamecnik, Colin R., Dandekar, Ravi, Alvarenga, Bonny D., Loudermilk, Rita P., Gerungan, Chloe, Spencer, Collin M., Sagan, Sharon A., Augusto, Danillo G., Alexander, Jessa, Hollenbach, Jill A., Wilson, Michael R., Zamvil, Scott S., Bove, Riley
Publicado 2021

Multiple sclerosis therapies differentially affect SARS-CoV-2 vaccine–induced antibody and T cell immunity and function

por Sabatino, Joseph J., Mittl, Kristen, Rowles, William M., McPolin, Kira, Rajan, Jayant V., Laurie, Matthew T., Zamecnik, Colin R., Dandekar, Ravi, Alvarenga, Bonny D., Loudermilk, Rita P., Gerungan, Chloe, Spencer, Collin M., Sagan, Sharon A., Augusto, Danillo G., Alexander, Jessa R., DeRisi, Joseph L., Hollenbach, Jill A., Wilson, Michael R., Zamvil, Scott S., Bove, Riley
Publicado 2022

A pathogenic and clonally expanded B cell transcriptome in active multiple sclerosis

por Ramesh, Akshaya, Schubert, Ryan D., Greenfield, Ariele L., Dandekar, Ravi, Loudermilk, Rita, Sabatino, Joseph J., Koelzer, Matthew T., Tran, Edwina B., Koshal, Kanishka, Kim, Kicheol, Pröbstel, Anne-Katrin, Banerji, Debarko, Guo, Chu-Yueh, Green, Ari J., Bove, Riley M., DeRisi, Joseph L., Gelfand, Jeffrey M., Cree, Bruce A. C., Zamvil, Scott S., Baranzini, Sergio E., Hauser, Stephen L., Wilson, Michael R.
Publicado 2020

A common allele of HLA mediates asymptomatic SARS-CoV-2 infection

por Augusto, Danillo G., Yusufali, Tasneem, Sabatino, Joseph J., Peyser, Noah D., Murdolo, Lawton D., Butcher, Xochitl, Murray, Victoria, Pae, Vivian, Sarvadhavabhatla, Sannidhi, Beltran, Fiona, Gill, Gurjot, Lynch, Kara, Yun, Cassandra, Maguire, Colin, Peluso, Michael J., Hoh, Rebecca, Henrich, Timothy J., Deeks, Steven G., Davidson, Michelle, Lu, Scott, Goldberg, Sarah A., Kelly, J. Daniel, Martin, Jeffrey N., Viera-Green, Cynthia A., Spellman, Stephen R., Langton, David J., Lee, Sulggi, Marcus, Gregory M., Olgin, Jeffrey E., Pletcher, Mark J., Gras, Stephanie, Maiers, Martin, Hollenbach, Jill A.
Publicado 2022

A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection

por Augusto, Danillo G., Murdolo, Lawton D., Chatzileontiadou, Demetra S. M., Sabatino, Joseph J., Yusufali, Tasneem, Peyser, Noah D., Butcher, Xochitl, Kizer, Kerry, Guthrie, Karoline, Murray, Victoria W., Pae, Vivian, Sarvadhavabhatla, Sannidhi, Beltran, Fiona, Gill, Gurjot S., Lynch, Kara L., Yun, Cassandra, Maguire, Colin T., Peluso, Michael J., Hoh, Rebecca, Henrich, Timothy J., Deeks, Steven G., Davidson, Michelle, Lu, Scott, Goldberg, Sarah A., Kelly, J. Daniel, Martin, Jeffrey N., Vierra-Green, Cynthia A., Spellman, Stephen R., Langton, David J., Dewar-Oldis, Michael J., Smith, Corey, Barnard, Peter J., Lee, Sulggi, Marcus, Gregory M., Olgin, Jeffrey E., Pletcher, Mark J., Maiers, Martin, Gras, Stephanie, Hollenbach, Jill A.
Publicado 2023